Bank of Montreal
SGMO

Bank of Montreal’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bank of Montreal’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-48,700
Closed -$511K – 3907
2013
Q3 		$511K Buy
+48,700
New +$484K ﹤0.01% 1794

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's SGMO Position: Q1 2025 in Review

Bank of Montreal sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 12,000 shares — an estimated $12.2K sold.

Bank of Montreal first reported a position in SGMO in Q1 2014 and held it in 39 quarters. The position peaked at $4.01M in Q4 2020. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Bank of Montreal reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 12,000 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $12.2K.
  • Bank of Montreal first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 39 quarters.
  • Bank of Montreal's SANGAMO THERAPEUTICS INC position peaked at $4.01M in Q4 2020.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.